P2P.org has become a validator on the Canton Network, a blockchain platform for institutional finance that handles more than $4 trillion in tokenized assets. As a validator, P2P.org will operate nodes ...

Ethereum’s proof-of-stake system is facing its largest test yet. As of mid-September, roughly 2.5 million ETH — valued at roughly $11.25 billion — is waiting to leave the validator set, according to ...

In a fairly new development for the Ethereum ecosystem, the validator exit queue has surged, reaching over 2.6 million ETH this week, a sharp rise from approximately 617,000 ETH just one week prior.

Pi Squared, the team building Web3 infrastructure beyond blockchain, has announced a strategic partnership with EigenCloud, the developer platform that extends the trust and verifiability of ...

Plus, how to gently tell your boss you have a better way of doing things. Credit...Margeaux Walter for The New York Times Supported by By Rachel Dry Send questions about the office, money, careers and ...

Greptile, a startup that’s building artificial intelligence-based code reviewers to validate human- and AI-generated software, has raised $25 million in an early-stage round of funding as it looks to ...

Shares of Opendoor Technologies Inc. rallied Thursday on the disclosure that quantitative-trading firm Jane Street Group LLC has amassed a stake in the e-commerce platform for residential-real-estate ...

After the big win at the 71st National Awards, actor Vikrant Massey admitted that it would now become challenging for him to represent the common man. Watch what he said about the national award being ...

Biogen recently announced that the U.S. FDA has accepted its investigational new drug (IND) application for BIIB142, an IRAK4 degrader developed in partnership with C4 Therapeutics, for exploration in ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Kenneth Harris, a NASA veteran who worked on ...

NEW YORK (AP) — As medical professionals react with alarm to President Donald Trump's unproven statements about Tylenol, childhood vaccines and autism, a different group of Americans is feeling ...